Subjects: BILIARY tract cancer; TUMOR growth; ATEZOLIZUMAB
Record details
Subjects: DRUG efficacy; DRUG approval; IMMUNE checkpoint inhibitors
Subjects: ULCERATIVE colitis; PHARMACOKINETICS; CLINICAL trials
Subjects: ATEZOLIZUMAB; IMMUNE response; CLINICAL pharmacology